2011, Number 1
Dermatología Cosmética, Médica y Quirúrgica 2011; 9 (1)
Bonifaz A, Araiza J, Ramírez DS, Ponce ORM
PDF size: 611.72 Kb.
ABSTRACTBackgroud: Dermatophytoses are keratin tissue infections caused by dermatophytes. Tinea pedis is the most prevalent dermatophytose. Sertaconazole is a wide-spectrum, third generation imidazole, with a good efficacy and safety profile for tineas, pityriasis versicolor and candidiasis.
Objective: to assess the efficacy and safety of sertaconazole in tinea pedis.
Material and methods: 30 patients with clinical and mycologycal diagnosis of tinea pedis were treated with sertaconazole cream 2% topically once daily for 4 weeks, and follow up of 4 weeks.
Results: Two etiologic agents were isolated in this study: Trichophyton rubrum in 93%, and Trichophyton interdigitale in 7%. All patients completed the study: Clinical and mycologycal cure in 86%, improvement in 6.33%, and failure in 6.33%. No side effects were reported.
Conclusion: Sertaconazole is a third generation imidazole considered as a new treatment for tinea pedis, with high efficacy and excellent safety.